NCT00720265View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

Prograf

oral

DRUG

MR4

oral

Trial Locations (2)

Unknown

Daegu

Seoul

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY